$NIVF
NewGenIvf Group Ltd Stock $nivf

$nivf Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000121390024070853 Filed on August 20, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$0.00	$5.136M	$0.00
YoY Change		-13.59%
Cost Of Revenue		$3.454M
YoY Change		-21.61%
Gross Profit		$1.682M
YoY Change		9.37%
Gross Profit Margin		32.74%
Selling, General & Admin	$1.266M	$1.277M	$120.0K
YoY Change	955.28%	12.93%
% of Gross Profit		75.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$31.17K
YoY Change		-68.99%
% of Gross Profit		1.85%
Operating Expenses	$1.266M	$1.640M	$120.0K
YoY Change	955.28%	43.94%
Operating Profit		$42.24K
YoY Change		-89.41%
Interest Expense	$310.9K	$1.831M	$590.0K
YoY Change	-47.31%	82.06%
% of Operating Profit		4333.96%
Other Income/Expense, Net		$66.18K
YoY Change		-220.94%
Pretax Income	-$955.5K	$108.4K	$470.0K
YoY Change	-303.3%	-68.48%
Income Tax	$0.00		$0.00
% Of Pretax Income			0.0%
Net Earnings	-$955.5K	$130.2K	$470.0K
YoY Change	-303.3%	-71.61%
Net Earnings / Revenue		2.53%
Basic Earnings Per Share		$0.18
Diluted Earnings Per Share	-$0.25	$0.18	$0.10
COMMON SHARES
Basic Shares Outstanding		615.1K shares
Diluted Shares Outstanding		615.1K shares

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$42.22K	$42.22K	$50.00K
YoY Change	-15.56%	-22.84%
Cash & Equivalents	$54.10K		$27.56K
Short-Term Investments
Other Short-Term Assets	$8.560K	$8.560K	$40.00K
YoY Change	-78.6%	-76.87%	-85.71%
Inventory	$126.3K		$46.91K
Prepaid Expenses
Receivables	$9.374K		$13.00K
Other Receivables
Total Short-Term Assets	$1.201M	$50.78K	$2.399M
YoY Change	-49.91%	-44.64%	756.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$162.2K		$122.7K
YoY Change	32.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$21.27M	$21.27M	$70.69M
YoY Change	-69.91%	-69.92%
Other Assets
YoY Change
Total Long-Term Assets	$446.0K	$21.27M	$506.3K
YoY Change	-11.92%	-69.92%	-14.52%
TOTAL ASSETS
Total Short-Term Assets	$1.201M	$50.78K	$2.399M
Total Long-Term Assets	$446.0K	$21.27M	$506.3K
Total Assets	$1.647M	$21.32M	$2.905M
YoY Change	-43.29%	-69.88%	937.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$172.6K	$617.4K	$104.7K
YoY Change	64.95%
Accrued Expenses			$50.00K
YoY Change			25.0%
Deferred Revenue	$7.937K		$1.360M
YoY Change	-99.42%
Short-Term Debt	$1.625M	$1.625M	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.122M	$2.242M	$2.556M
YoY Change	-56.08%	4384.54%	922.26%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.480M	$3.480M	$2.420M
YoY Change	43.78%	44.08%
Total Long-Term Liabilities	$119.0K	$3.480M	$248.6K
YoY Change	-52.15%	44.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.122M	$2.242M	$2.556M
Total Long-Term Liabilities	$119.0K	$3.480M	$248.6K
Total Liabilities	$1.241M	$5.722M	$2.804M
YoY Change	-55.73%	132.12%	1021.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$461.4K		-$591.5K
YoY Change	-22.01%
Common Stock	$4.332M		$1.465M
YoY Change	195.7%		468.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$896.1K	$15.60M	$563.1K
YoY Change
Total Liabilities & Shareholders Equity	$1.647M	$21.32M	$2.905M
YoY Change	-43.29%	-69.88%	937.49%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	-$955.5K	$130.2K	$470.0K
YoY Change	-303.3%	-71.61%
Depreciation, Depletion And Amortization		$31.17K
YoY Change		-68.99%
Cash From Operating Activities	-$141.5K	-$1.766M	-$40.00K
YoY Change	253.82%	-203.23%
INVESTING ACTIVITIES
Capital Expenditures		$69.85K
YoY Change		-26.05%
Acquisitions
YoY Change
Other Investing Activities	$18.30M	$51.25M	$0.00
YoY Change		-173.55%
Cash From Investing Activities	$18.30M	-$69.85K	$0.00
YoY Change		-26.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$192.3K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-18.15M	$1.881M	0.000
YoY Change		-215.16%
NET CHANGE
Cash From Operating Activities	-141.5K	-$1.766M	-40.00K
Cash From Investing Activities	18.30M	-$69.85K	0.000
Cash From Financing Activities	-18.15M	$1.881M	0.000
Net Change In Cash	3.470K	$45.51K	-40.00K
YoY Change	-108.67%	-362.58%
FREE CASH FLOW
Cash From Operating Activities	-$141.5K	-$1.766M	-$40.00K
Capital Expenditures		$69.85K
Free Cash Flow		-$1.836M
YoY Change		-213.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-42004
CY2023	dei	Entity Registrant Name EntityRegistrantName	NewGenIVF GROUP LIMITED
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D8
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	36/39-36/40, 13th Floor, PS TowerSukhumvit 21 Road (Asoke)
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Khlong Toei Nuea Sub-district
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Watthana District
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Bangkok
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10110
CY2023	dei	Entity Address Country EntityAddressCountry	TH
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	6732
CY2023	dei	Auditor Name AuditorName	Onestop Assurance PAC
CY2023	dei	Auditor Location AuditorLocation	Singapore
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54104	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27556	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9374	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	126264	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	46910	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	517429	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	70285	usd
CY2023Q4	nivf	Loan To Aspac LoanToASPAC	140000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1201456	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	2398623	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	162157	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	122673	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	283847	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	383670	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	446004	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	506343	usd
CY2023Q4	us-gaap	Assets Assets	1647460	usd
CY2022Q4	us-gaap	Assets Assets	2904966	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	172626	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	104651	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	241613	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	289777	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7937	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1360168	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	207128	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	184651	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	6446	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	18758	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	486706	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	486872	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1122456	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2555650	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	118979	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	242187	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6446	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	118979	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	248633	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1241435	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2804283	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	698123	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	698123	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	601830	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	601830	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	6981	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	6018	usd
CY2023Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	2967100	usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	319872	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4324834	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1458941	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-461351	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-591544	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7288	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	9570	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	896076	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	563113	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-490051	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-462430	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	406025	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	100683	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1647460	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2904966	usd
CY2023	us-gaap	Revenues Revenues	5136153	usd
CY2022	us-gaap	Revenues Revenues	5944190	usd
CY2021	us-gaap	Revenues Revenues	4118120	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	3454368	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	4406421	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	3093340	usd
CY2023	us-gaap	Gross Profit GrossProfit	1681785	usd
CY2022	us-gaap	Gross Profit GrossProfit	1537769	usd
CY2021	us-gaap	Gross Profit GrossProfit	1024780	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	18030	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	36194	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	24693	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1259364	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1094962	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	801329	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	362149	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	7908	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1639543	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1139064	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	826022	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	42242	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	398705	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	198758	usd
CY2023	us-gaap	Other Income OtherIncome	111837	usd
CY2022	us-gaap	Other Income OtherIncome	23019	usd
CY2021	us-gaap	Other Income OtherIncome	45652	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	518	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	21	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	63	usd
CY2023	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	46179	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	77757	usd
CY2021	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	88289	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	66176	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-54717	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-42574	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	108418	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	343988	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	156184	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	208141	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	294716	usd
CY2023	us-gaap	Profit Loss ProfitLoss	108418	usd
CY2022	us-gaap	Profit Loss ProfitLoss	135847	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-138532	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-21775	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-322820	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-137999	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	130193	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	458667	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-533	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-22704	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1920	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7751	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	85714	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	133927	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-130781	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-27621	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-323458	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-136396	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	113335	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	457385	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5615	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.8
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	615135	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	575930	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	560000	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-984129	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-138532	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7751	usd
CY2021	nivf	Stock Issued During Period Value Directors Remuneration StockIssuedDuringPeriodValueDirectorsRemuneration	200000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-914910	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-914910	usd
CY2022	us-gaap	Profit Loss ProfitLoss	135847	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1920	usd
CY2022	nivf	Stock Issued During Period Value Directors Remuneration StockIssuedDuringPeriodValueDirectorsRemuneration	240000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	641666	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	100683	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	100683	usd
CY2023	us-gaap	Profit Loss ProfitLoss	108418	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-22704	usd
CY2023	nivf	Stock Issued During Period Value Settlement Of Subscription Receivable StockIssuedDuringPeriodValueSettlementOfSubscriptionReceivable	219628	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	406025	usd
CY2023	us-gaap	Profit Loss ProfitLoss	108418	usd
CY2022	us-gaap	Profit Loss ProfitLoss	135847	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-138532	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31173	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	100533	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	166709	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	198535	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	203411	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	175830	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-114013	usd
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	625	usd
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	10777	usd
CY2021	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	6717	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	46179	usd
CY2023	nivf	Waiver Of Related Party Balance WaiverOfRelatedPartyBalance	88151	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	240000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	200000	usd
CY2023	us-gaap	Legal Fees LegalFees	27320	usd
CY2022	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	208141	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1166	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-129922	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-56183	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	80665	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7219	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1352	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	448266	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	15197	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-10987	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	71362	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	58752	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-60989	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-51167	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	190689	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	79853	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1352231	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	548010	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	812158	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-230433	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-175132	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-148677	usd
CY2022	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	19476	usd
CY2021	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	19476	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-12170	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	290887	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1766135	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1710901	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1433002	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	69848	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	94452	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16575	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-69848	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-94452	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16575	usd
CY2023	nivf	Proceeds From Amount Due From Aspaci ProceedsFromAmountDueFromASPACI	140000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	9317	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	19476	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	17221	usd
CY2022	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	128204	usd
CY2021	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	512821	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	192308	usd
CY2023	nivf	Paymentof Interest PaymentofInterest	24704	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	1863206	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-1742509	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-2039969	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1881493	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1633781	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1544369	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	45510	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-17332	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-127942	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-18962	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16124	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50514	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27556	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28764	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106192	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54104	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27556	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28764	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	12170	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	3829	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	24704	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	55469	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	65582	usd
CY2023Q4	us-gaap	Policyholder Dividends Rate On Policy Earnings PolicyholderDividendsRateOnPolicyEarnings	0.15	pure
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54104	usd
CY2023Q4	us-gaap	Other Secured Financings OtherSecuredFinancings	2000000	usd
CY2023	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	2000000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="text-decoration:underline">Use of estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant estimates required to be made by management include, but are not limited to, contingent tax liability for Kyrgyzstan. Actual results could differ from those estimates, and as such, differences may be material to the consolidated financial statements.</p>
CY2023Q4	us-gaap	Property Plant And Equipment Salvage Value Percentage PropertyPlantAndEquipmentSalvageValuePercentage	0	pure
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	nivf	Revenue Rate RevenueRate	0.40	pure
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	283847	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	383670	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	326107	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	426838	usd
CY2023	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.00125	pure
CY2023Q4	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.066	pure
CY2022Q4	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.05	pure
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="text-decoration:underline">Concentration of risks</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>Concentration of credit risk</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Financial instruments that potentially expose us to concentrations of credit risk consist primarily of cash and cash equivalents and account receivable. The Company places cash and cash equivalents with financial institutions with high credit ratings and quality.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accounts receivable primarily comprise of amounts receivable from the service customers. The Company conducts credit evaluations of customers, and generally does not require collateral or other security from its customers. The Company establishes an allowance for doubtful accounts primarily based upon the factors surrounding the credit risk of specific customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>Concentration of customers</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of December 31, 2023 and 2022, two and Nil customers which individually contributed more than 10% of trade receivable, accounted for 96.3% and <span style="-sec-ix-hidden: hidden-fact-83">Nil</span> of the Company’s trade receivable respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">None of the customers contributed more than 10% of revenue for years ended December 31, 2023, 2022 and 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Concentration of suppliers</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of December 31, 2023 and 2022, one and four suppliers which individually contributed more than 10% of trade payable, accounted for 30.6% and 69.8% of the Company’s trade payable respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the year ended December 31, 2023, 2022 and 2021, Nil, two and two vendors which contributed more than 10% of total purchases of the Company, accounted for <span style="-sec-ix-hidden: hidden-fact-84">Nil</span>, 55.3% and 35.6% of the Company’s total purchases respectively.</p>
CY2023	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.05	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.05	pure
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	9393	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	13026	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	19	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	26	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9374	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9374	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13000	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	126264	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	46910	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	126264	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	46910	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	15910	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	30295	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	123008	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	40131	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4848	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	373677	usd
CY2023Q4	us-gaap	Premiums Receivable Allowance For Doubtful Accounts PremiumsReceivableAllowanceForDoubtfulAccounts	14	usd
CY2022Q4	us-gaap	Premiums Receivable Allowance For Doubtful Accounts PremiumsReceivableAllowanceForDoubtfulAccounts	141	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	517429	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	70285	usd
CY2022Q4	nivf	Allowances For Expected Credit Loss AllowancesForExpectedCreditLoss	-141	usd
CY2021Q4	nivf	Allowances For Expected Credit Loss AllowancesForExpectedCreditLoss	-115	usd
CY2023	nivf	Allowances For Expected Credit Loss Reversal Of Provision Provision AllowancesForExpectedCreditLossReversalOfProvisionProvision	127	usd
CY2022	nivf	Allowances For Expected Credit Loss Reversal Of Provision Provision AllowancesForExpectedCreditLossReversalOfProvisionProvision	-30	usd
CY2022	nivf	Allowances For Expected Credit Loss Effect Of Currency Translation Adjustment AllowancesForExpectedCreditLossEffectOfCurrencyTranslationAdjustment	4	usd
CY2023Q4	nivf	Allowances For Expected Credit Loss AllowancesForExpectedCreditLoss	-14	usd
CY2022Q4	nivf	Allowances For Expected Credit Loss AllowancesForExpectedCreditLoss	-141	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1481364	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1400083	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1319207	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1277410	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	162157	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	122673	usd
CY2023	us-gaap	Depreciation Depreciation	31173	usd
CY2022	us-gaap	Depreciation Depreciation	100533	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	114013	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	43633	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	22345	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	3180	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	7349	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	82240	usd
CY2023Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	144015	usd
CY2022Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	117935	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	46616	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	64077	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	241613	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	289777	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1360168	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	812158	usd
CY2023	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	112006	usd
CY2022	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	1360168	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-122662	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-812158	usd
CY2023Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	1341575	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7937	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1360168	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	283847	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	383670	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	207128	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	184651	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	118979	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	242187	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	326107	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	426838	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y11M1D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y10M28D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	114937000000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	89380000000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	240835	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	111613	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	10373	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	362821	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	36714	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	326107	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2023	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	698123	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	601830	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	6981	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	6018	usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	319872	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2866856	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	319872	usd
CY2023	nivf	Stock Issued During Period Value Settlement Of Subscription Receivable StockIssuedDuringPeriodValueSettlementOfSubscriptionReceivable	219628	usd
CY2023Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	2967100	usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	319872	usd
CY2022Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	41830	shares
CY2022Q3	us-gaap	Other Borrowings OtherBorrowings	641025	usd
CY2022Q3	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	319872	usd
CY2023Q1	us-gaap	Amount Of Regulatory Assistance Received1 AmountOfRegulatoryAssistanceReceived1	192308	usd
CY2023Q1	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	192308	usd
CY2023Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	27293	shares
CY2023Q1	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	812573	usd
CY2023Q4	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	69000	shares
CY2023Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	2054283	shares
CY2023Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	27320	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1458941	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	257821	usd
CY2022	nivf	Stock Issued During Period Value Directors Remuneration StockIssuedDuringPeriodValueDirectorsRemuneration	240000	usd
CY2023	nivf	Issuance Of Shares Additionalpaidincapital IssuanceOfSharesAdditionalpaidincapital	2865893	usd
CY2022	nivf	Issuance Of Shares Additionalpaidincapital IssuanceOfSharesAdditionalpaidincapital	961120	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4324834	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1458941	usd
CY2023Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	240000	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	41830	shares
CY2022Q3	us-gaap	Other Additional Capital OtherAdditionalCapital	961120	usd
CY2023Q1	us-gaap	Shares Issued SharesIssued	27293	shares
CY2023Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	2053593	usd
CY2023	us-gaap	Management And Service Fees Rate ManagementAndServiceFeesRate	0.08	pure
CY2023	nivf	Profit Tax Description ProfitTaxDescription	Under the two-tiered profits tax rates regime, Hong Kong tax residents are subject to Hong Kong Profits Tax in respect of profits arising in or derived from Hong Kong at 8.25% for the first HK$2 million of profits of the qualifying group entity, and profits above HK$2 million will be taxed at 16.5%. The profits of group entities not qualifying for the two-tiered profits tax rates regime will continue to be taxed at a flat rate of 16.5%.
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0825	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Investment EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment	0.165	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Other EffectiveIncomeTaxRateReconciliationTaxSettlementsOther	0.20	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0.15	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.10	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	0.20	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.10	pure
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	208141	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	108418	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	343988	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	156184	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	10732	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-124591	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	36755	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-39173	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	369101	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	114656	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	145295	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	28441	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-36369	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-1990	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	208141	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	294716	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	28441	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	28441	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	164721	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	297207	usd
CY2023	nivf	Percentage Of Allowance On Deferred Tax Assets PercentageOfAllowanceOnDeferredTaxAssets	1	pure
CY2023	us-gaap	Revenues Revenues	5136153	usd
CY2022	us-gaap	Revenues Revenues	5944190	usd
CY2021	us-gaap	Revenues Revenues	4118120	usd
CY2023	us-gaap	Revenues Revenues	5136153	usd
CY2022	us-gaap	Revenues Revenues	5944190	usd
CY2021	us-gaap	Revenues Revenues	4118120	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	446004	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	506343	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	592378	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	19	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	26	usd
CY2023	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.01	pure
CY2023	nivf	Interest Rate Other Variables Percentage InterestRateOtherVariablesPercentage	0.01	pure
CY2023	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	541	usd
CY2022	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	275	usd
CY2021	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	287	usd
CY2023Q4	nivf	Due From Shareholders DueFromShareholders	354285	usd
CY2022Q4	nivf	Due From Shareholders DueFromShareholders	2240872	usd
CY2023Q4	nivf	Due From Shareholder DueFromShareholder	372103	usd
CY2022Q4	nivf	Due From Shareholder DueFromShareholder	2257931	usd
CY2023Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	17818	usd
CY2022Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	17059	usd
CY2023Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	354285	usd
CY2022Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	2240872	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	17059	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6312	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-759	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-10747	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	17818	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	17059	usd
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	560000	usd
CY2023	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	140000	usd
CY2023Q4	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	486706	usd
CY2023	nivf	Number Of Operating Segment NumberOfOperatingSegment	1	pure
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	pure
CY2022Q4	nivf	Loan To Aspac LoanToASPAC		usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2021	us-gaap	Professional Fees ProfessionalFees		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.80
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	560000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	575930	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	615135	shares
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2022	nivf	Waiver Of Related Party Balance WaiverOfRelatedPartyBalance		usd
CY2021	nivf	Waiver Of Related Party Balance WaiverOfRelatedPartyBalance		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	us-gaap	Legal Fees LegalFees		usd
CY2021	us-gaap	Legal Fees LegalFees		usd
CY2023	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense		usd
CY2021	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense		usd
CY2023	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables		usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2022	nivf	Proceeds From Amount Due From Aspaci ProceedsFromAmountDueFromASPACI		usd
CY2021	nivf	Proceeds From Amount Due From Aspaci ProceedsFromAmountDueFromASPACI		usd
CY2023	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	nivf	Paymentof Interest PaymentofInterest		usd
CY2021	nivf	Paymentof Interest PaymentofInterest		usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent		usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2023	nivf	Allowances For Expected Credit Loss Effect Of Currency Translation Adjustment AllowancesForExpectedCreditLossEffectOfCurrencyTranslationAdjustment		usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf		usd
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf		usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent		usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability		usd
CY2021Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2022	nivf	Stock Issued During Period Value Settlement Of Subscription Receivable StockIssuedDuringPeriodValueSettlementOfSubscriptionReceivable		usd
CY2023	nivf	Stock Issued During Period Value Directors Remuneration StockIssuedDuringPeriodValueDirectorsRemuneration		usd
CY2023Q4	us-gaap	Special Assessment Bond SpecialAssessmentBond	450	thb
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther		usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther		usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense		usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments		usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments		usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance		usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance		usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q4	us-gaap	Contract With Customer Receivable Allowance For Credit Loss ContractWithCustomerReceivableAllowanceForCreditLoss		usd
CY2022Q4	us-gaap	Contract With Customer Receivable Allowance For Credit Loss ContractWithCustomerReceivableAllowanceForCreditLoss		usd
CY2021Q4	us-gaap	Contract With Customer Receivable Allowance For Credit Loss ContractWithCustomerReceivableAllowanceForCreditLoss		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001981662

Files In Submission

Name	View Source	Status
0001213900-24-070853-index-headers.html	Edgar Link	pending
0001213900-24-070853-index.html	Edgar Link	pending
0001213900-24-070853.txt	Edgar Link	pending
0001213900-24-070853-xbrl.zip	Edgar Link	pending
ea0211229-20f_newgen.htm	Edgar Link	pending
ea021122901ex12-1_newgen.htm	Edgar Link	pending
ea021122901ex12-2_newgen.htm	Edgar Link	pending
ea021122901ex13-1_newgen.htm	Edgar Link	pending
ea021122901ex13-2_newgen.htm	Edgar Link	pending
ea021122901ex14-1_newgen.htm	Edgar Link	pending
ea021122901ex15-1_newgen.htm	Edgar Link	pending
ea021122901ex16-1_newgen.htm	Edgar Link	pending
ea021122901ex19-1_newgen.htm	Edgar Link	pending
ea021122901ex8-1_newgen.htm	Edgar Link	pending
ea021122901ex97-1_newgen.htm	Edgar Link	pending
ex15-1_001.jpg	Edgar Link	pending
ex15-1_002.jpg	Edgar Link	pending
ex15-1_003.jpg	Edgar Link	pending
ex16-1_001.jpg	Edgar Link	pending
ea0211229-20f_newgen_htm.xml	Edgar Link	completed
ex16-1_002.jpg	Edgar Link	pending
ex16-1_003.jpg	Edgar Link	pending
ex8-1_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nivf-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nivf-20231231_cal.xml	Edgar Link	unprocessable
nivf-20231231_def.xml	Edgar Link	unprocessable
nivf-20231231_lab.xml	Edgar Link	unprocessable
nivf-20231231_pre.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NIVF
NewGenIvf Group Ltd Stock $nivf

2023 Q4 Form 20-F Financial Statement

#000121390024070853 Filed on August 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NIVF NewGenIvf Group Ltd Stock $nivf

2023 Q4 Form 20-F Financial Statement

#000121390024070853 Filed on August 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NIVF
NewGenIvf Group Ltd Stock $nivf